Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer.

作者: Robert Vander Broek Anthony D Saleh

DOI: 10.4172/2157-2518.S7-004

关键词:

摘要: Head and neck squamous cell carcinoma (HNSCC) arises from the upper aerodigestive tract is six most common cancers worldwide. HNSCC associated with high morbidity mortality, as standard surgery, radiation, chemotherapy can cause significant disfigurement only provide 5-year survival rates of ~50- 60%. The heterogeneity subsets different potentials for recurrence metastasis challenges traditional pathological classification system, thereby increasing demand development new diagnostic, prognostic, therapeutic tools based on global molecular signatures HNSCC. Historically, using classical biological techniques, it has been extremely difficult time-consuming to survey hundreds or thousands genes in a given disease. However, throughput technologies high-powered computation throughout last two decades enabled us investigate simultaneously. Using technologies, our laboratory identified gene protein networks, which significantly affect malignant phenotypes, including TP53/p63/p73 family members, IL-1/TNF-β/NF-κB, PI3K/AKT/mTOR, IL-6/IL-6R/JAK/STAT3, EGFR/MAPK/AP1, HGF/cMET/EGR1, TGFβ/TGFβR/TAK1/SMAD pathways. This review summarizes results high-throughput technological assays conducted samples, microarray, DNA methylation, miRNA profiling, array, primarily experimental data conclusions generated own laboratory. use bioinformatics integrated analyses sets platforms, well meta-analysis large datasets pulled multiple publicly available studies, provided higher statistical power extract biologically relevant information. suggested that genotype phenotype are much more complex than we previously thought. Understanding disease specific will be essential accurate diagnoses targeted therapy personalized treatment, an important effort toward improving patient outcomes.

参考文章(125)
Mariaelena Pierobon, Claudio Belluco, Lance A. Liotta, Emanuel F. Petricoin, Reverse Phase Protein Microarrays for Clinical Applications Methods of Molecular Biology. ,vol. 785, pp. 3- 12 ,(2011) , 10.1007/978-1-61779-286-1_1
James L. Gulley, Jame Abraham, Carmen J. Allegra, Bethesda Handbook of Clinical Oncology ,(2001)
Seong-Yeon Park, Jung Hyun Lee, Minju Ha, Jin-Wu Nam, V Narry Kim, miR-29 miRNAs activate p53 by targeting p85α and CDC42 Nature Structural & Molecular Biology. ,vol. 16, pp. 23- 29 ,(2009) , 10.1038/NSMB.1533
Carter Van Waes, Caren C. Bancroft, John B. Sunwoo, Gang Dong, Ning Yeh, Catherine Park, Zhong Chen, Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways Clinical Cancer Research. ,vol. 7, pp. 435- 442 ,(2001)
Yoshihisa Watanabe, Masato Maekawa, Methylation of DNA in Cancer Advances in Clinical Chemistry. ,vol. 52, pp. 145- 167 ,(2010) , 10.1016/S0065-2423(10)52006-7
Elizabeth Van Tubergen, Robert Vander Broek, Julia Lee, Gregory Wolf, Thomas Carey, Carol Bradford, Mark Prince, Keith L. Kirkwood, Nisha J. D'Silva, Tristetraprolin regulates interleukin‐6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma Cancer. ,vol. 117, pp. 2677- 2689 ,(2011) , 10.1002/CNCR.25859
Josena K. Stephen, Kang Mei Chen, Shaleta Havard, Glynis Harris, Maria J. Worsham, Promoter methylation in head and neck tumorigenesis. Methods of Molecular Biology. ,vol. 863, pp. 187- 206 ,(2012) , 10.1007/978-1-61779-612-8_11
Mark P. Boldin, David Baltimore, MicroRNAs, new effectors and regulators of NF-κB Immunological Reviews. ,vol. 246, pp. 205- 220 ,(2012) , 10.1111/J.1600-065X.2011.01089.X